Deutsche Bank Cuts PT on Sanofi (SNY) – Here’s Why
Sanofi (NASDAQ:SNY) is one of the best low volatility stocks to buy under $50.
Posts Tagged ‘Sanofi (NASDAQ:SNY)’
12 Best NASDAQ Stocks to Buy for Dividends
Dividends offer investors a reliable source of income, but when it comes to building long-term wealth, capital appreciation has usually done most of the heavy lifting.
10 Best Low Volatility Stocks to Buy Under $50
On June 18, Tom Lee, Fundstrat's Managing Partner and Head of Research, appeared on CNBC's ‘Closing Bell’ to talk about where stocks are headed from Thursday’s levels.
Is Sanofi (SNY) Approaching a Breakthrough in Rare Neurological Disease Treatment?
TheFly reported on May 27 that the US Food and Drug Administration (FDA) has granted priority review to SNY’s New Drug Application for venglustat, an investigational oral glucosylceramide...
11 Most Undervalued Pharma Stocks to Invest In
Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.
Sanofi (SNY) Announces Financial Results for Q1 2026
Sanofi (NASDAQ:SNY) is one of the best stem cell therapy stocks to buy.
8 Best Stem Cell Therapy Stocks to Buy
On April 23, Bankim Chadha, chief global strategist at Deutsche Bank, appeared on CNBC's ‘Money Movers’ to talk about uncertainty in the markets and what to expect with the...
10 Best Global Stocks to Buy According to Wall Street Analysts
International equities outperformed the US stock market in 2025.
10 Best Affordable Blue Chip Stocks to Buy Now
The S&P 500 closed at an all-time high on April 17, as hopes of a de-escalation in the Middle East war and robust earnings expectations in the current Q1 earnings season drew...
15 Large-cap Stocks with Highest Dividends
Large-cap stocks are usually issued by established companies with long track records. These are often well-known names that have been operating for years.
FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports
Sanofi (NASDAQ:SNY) is one of the best undervalued stocks under $50 to invest in now. Sanofi (NASDAQ:SNY) announced on March 18 that the US Food and Drug Administration (FDA) ...
15 Best Undervalued Stocks Under $50 to Invest In Now
On March 20, Tom Lee, Fundstrat, appeared on CNBC's ‘Power Lunch’ to talk about his price target for the S&P and the potential of the market to rise higher.
Sanofi (SNY) and Regeneron’s Dupixent Recommended for EU Approval
Sanofi (NASDAQ:SNY) is one of the best cheap stocks under $50 to buy right now.
15 Cheap Stocks Under $50 to Buy Right Now
On February 26, Ed Yardeni, Yardeni Research president, appeared on CNBC’s 'Closing Bell' to talk about his thoughts on the tech trade and the market's standings.
Sanofi’s (SNY) R&D Track Record Remains Investor Concern, Says BofA
TheFly reported that on February 20, SNY’s price target was lowered at Citi by EUR 5.
7 Oversold Pharma Stocks to Buy Now
In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected to have grown to $883.97 billion.
Manuela Buxo To Become Head of Sanofi’s (SNY) Specialty Care Global Business Unit
Sanofi (NASDAQ:SNY) is one of the Best Dip Stocks to Buy According to Hedge Funds.
11 Best Dip Stocks to Buy According to Hedge Funds
On February 17, Mohamed El-Erian, Chief Economic Advisor at Allianz, appeared on a CNBC Television interview to discuss the way forward amidst the volatility.
Is Sanofi (SNY) One of the Best Healthcare Stocks Under $50 to Invest In?
Sanofi (NASDAQ:SNY) is one of the best healthcare stocks under $50 to invest in.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage...
Sanofi (SNY) Strengthens Shareholder Returns Amid Robust 2025 Performance and Long-Term Growth Outlook
Sanofi (NASDAQ:SNY) is one of the best 52-week low blue-chip stocks to buy right now.
10 Best 52-Week Low Blue Chip Stocks to Buy Right Now
The S&P 500 has performed exceedingly well over the past two years, powering to all-time highs amid easing inflation and the artificial intelligence boom.
10 Most Undervalued Foreign Stocks to Buy According to Analysts
On January 1, Todd Gordon from Inside Edge Capital appeared on CNBC to discuss the state of global markets.
Sanofi (SNY) Secures Approval for Cablivi in the US and Plozasiran in China
Sanofi (NASDAQ:SNY) is one of the best blue-chip stocks to buy for 2026.
10 Best Blue Chip Stocks to Buy for 2026
Blue-chip stocks are set to dominate the pace and direction of the US equity market.
Sanofi (SNY) Reports Regulatory Win, Barclays Downgrades to ‘Equal Weight’ with EUR 85 PT
On January 6, 2026, Barclays downgraded Sanofi (NASDAQ:SNY) from ‘Overweight’ to ‘Equal Weight’, while setting an EUR 85 price target.
11 Most Undervalued Blue Chip Stocks to Buy Now
As we enter 2026, U.S. equities are expected to enter a phase marked by several complexities following the outsized gains in 2025.
Jefferies Maintains Buy on Sanofi (SNY) Despite Regulatory Overhang
Sanofi (NASDAQ:SNY) is among the ridiculously cheap stocks to buy now.
13 Ridiculously Cheap Stocks to Buy Now
Markets are hardly rational, and that’s what makes things so interesting.
Where is Sanofi (SNY) Headed According to Wall Street?
Sanofi (NASDAQ:SNY) is one of the best affordable healthcare stocks to buy now.
10 Best Affordable Healthcare Stocks to Buy Now
On December 26, Bernstein analyst Lance Wilkes appeared on CNBC to talk about the outlook for the managed care providers in 2026, along with how the rising healthcare costs could...
Delayed MS Decision and Trial Miss Add to Sanofi’s R&D Challenges
Sanofi (NASDAQ:SNY) said on December 15 that a US regulatory decision for its experimental multiple sclerosis drug will be delayed again.
15 Global Dividend Stocks to Diversify Your Portfolio
Dividend stocks are back in focus, and not just in the US, but investors around the world are leaning into income again, and the data shows why.
15 Best Affordable Stocks to Buy According to Analysts
On December 24, Kevin Mahn, President and CIO of Hennion & Walsh Asset Management, appeared on a CNBC Television interview to discuss his market outlook for 2026.
Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades
Between December 8 and December 10, 2025, SNY faced a series of analyst rating adjustments that tempered investor sentiment.
9 Most Undervalued Pharma Stocks to Buy Right Now
The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.
Sanofi (SNY) Sees Slight Pessimism From Analysts
Sanofi (NASDAQ:SNY) is a French pharmaceutical firm that has been at the center of several analysts’ attention lately.
13 Best ADR Stocks to Invest In
ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America.
JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EUR 105
Sanofi (NASDAQ:SNY) is one of the best pharma stocks to invest in. Sanofi (NASDAQ:SNY) was downgraded to Neutral from Overweight by JPMorgan on December 8, with the firm also...
Why Wall Street Analysts Are Closely Watching Sanofi (SNY)
Sanofi (NASDAQ:SNY) is among the cheap healthcare stocks to buy heading into 2026.
11 Best Pharma Stocks to Invest In
CNBC reported on December 1 that the UK and US governments reached a deal on drug pricing.
12 Cheap Healthcare Stocks to Buy Heading into 2026
Since the pandemic, healthcare is one of the sectors that have remained in the spotlight even amid market twists.
12 Cheap NASDAQ Stocks to Buy Now
On December 3, Michael Kantrowitz, Chief Investment Strategist at Piper Sandler, appeared on CNBC television to discuss the market outlook for 2026.
Deutsche Bank Maintains a Buy Rating on Sanofi (SNY)
Sanofi (NASDAQ:SNY) is one of the best low volatility large cap stocks to invest in.
10 Best Low Volatility Large Cap Stocks to Invest In
On November 24, Fundstrat's global head of technical strategy, Mark Newton, appeared on CNBC’s 'Squawk Box' to talk about what to make of the recent volatility in the stock ...
11 Best and Cheap Stocks to Buy Right Now
On October 3, Wharton professor and WisdomTree Chief Economist Jeremy Siegel joined CNBC for an interview to discuss the current and near-future outlook for the stock market.
Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating
On September 29, Berenberg reaffirmed its Buy rating on Sanofi (NASDAQ:SNY) with a price target of EUR110.00, citing better returns from the company’s medication pipeline.
12 Best Widow and Orphan Stocks to Buy According to Analysts
According to Reuters, U.S. stock index futures increased on September 29.
12 Ridiculously Cheap Stocks to Buy According to Analysts
On September 25, Katie Stockton, founder and managing partner of Fairlead Strategies, joined CNBC for an interview to discuss the latest market signals to watch.
11 Best Low Cost Stocks to Buy According to Analysts
On September 13, Courtney Garcia, Payne Capital Management senior wealth advisor, appeared in an interview on CNBC to discuss the markets.
Hedge Fund Resource Center
